SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001172661-23-002651
Filing Date
2023-07-28
Accepted
2023-07-28 09:01:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 polar-agle071923.htm SC 13G 108563
  Complete submission text file 0001172661-23-002651.txt   110057
Mailing Address 221 CRESCENT STREET BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 17, SUITE 102B WALTHAM MA 02453 6176515940
Aeglea BioTherapeutics, Inc. (Subject) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89456 | Film No.: 231120373
SIC: 2834 Pharmaceutical Preparations

Mailing Address 16 PALACE STREET LONDON X0 SW1E 5JD
Business Address 16 PALACE STREET LONDON X0 SW1E 5JD 02072272700
Polar Capital Holdings Plc (Filed by) CIK: 0001837309 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0331
Type: SC 13G